SYNTERACTHCR DENMARK ApS: Financial statements 2022
CVR: 34055572
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
SYNTERACTHCR DENMARK ApS (CVR 34055572) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,546 and a net result of DKK -168,380 compared with DKK -266,317 the year before. That is an increase of 224.1% compared with the year before. Equity in the 2022 report amounted to DKK 21,934. The solvency ratio was 42%.
- Gross Profit
- DKK 3,546
- Profit/Loss
- DKK -168,380
- Equity
- DKK 21,934
- Total Assets
- DKK 52,169
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 4 t. | -168 t. | 22 t. | - |
| 2021 | - | 1 t. | -266 t. | -8.6 mio. | - |
| 2020 | - | 2 t. | -291 t. | -8.4 mio. | - |
| 2019 | - | 2 t. | -290 t. | -8.1 mio. | - |
| 2018 | - | 3 t. | -279 t. | -7.8 mio. | - |
Official annual report
Keep an eye on SYNTERACTHCR DENMARK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
SYNTERACTHCR DENMARK ApS has published its annual report for 2021. Gross profit came to DKK 1,094, and the net result was DKK -266,317.
About SYNTERACTHCR DENMARK ApS
SYNTERACTHCR DENMARK ApS was a Danish company of the type Anpartsselskab based in Valby, founded in 2011. The company has been dissolved on 15 May 2024. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named HARRISON CLINICAL RESEARCH SCANDINAVIA ApS. The company has 0 employees (2014). In 2022, the company reported a gross profit of DKK 3,546 and a net result of DKK -168,380 compared with DKK -266,317 the year before. Equity in the 2022 report amounted to DKK 21,934.